Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study

American Journal of Medicine

Volumn 115, Issue 6, 2003, Pages 429-435

  Roubenoff, Ronenn ^a,g   Parise, Helen ^b   Payette, Hélène A ^a,c   Abad, Leslie W ^a   D'Agostino, Ralph ^b   Jacques, Paul F ^a   Wilson, Peter W F ^b,d   Dinarello, Charles A ^e   Harris, Tamara B ^f  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d FRAMINGHAM HEART STUDY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAT; INTERLEUKIN 1BETA; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGED; AGING; ARTICLE; BODY MASS; COMMUNITY; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; GENDER; HEALTH STATUS; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MORTALITY; MUSCLE ATROPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SMOKING;

EID: 0141892842     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.05.001     Document Type: Article

References (26)

1. Roubenoff R., Hughes V. Sarcopenia current concepts . J Gerontol. 55A:2000;M716-M724.
2. Harris T., Kiel D., Roubenoff R., et al. Association of insulin-like growth factor-1 with body composition weight history, and past health behaviors in the very old: the Framingham Heart Study . J Am Geriatr Soc. 45:1997;133-139.
3. Roubenoff R., Harris T., Abad L., Wilson P., Dallal G., Dinarello C. Monocyte cytokine production in an elderly population effect of age and inflammation . J Gerontol. 53A:1998;M20-M26.
4. Steel D., Whitehead A. The major acute phase reactants C-reactive protein, serum amyloid P component and serum amyloid A protein . Immunol Today. 15:1994;81-88.
5. Ferrucci L., Harris T., Guralnik J., et al. Serum IL-6 level and development of disability in older persons. J Am Gerontol Soc. 47:1999;639-646.
6. Taaffe D., Harris T., Ferrucci L., Rowe J., Seeman T. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons MacArthur studies of successful aging . J Gerontol. 55A:2000;M709-M715.
7. Volpato S., Guralnik J., Ferrucci L., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women. Circulation. 103:2001;947-953.
8. Harris T., Ferrucci L., Tracy R., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 106:1999;506-512.
9. Visser M., Harris T., Langlois J., et al. Body fat and skeletal muscle mass in relation to physical disability in very old men and women of the Framingham Heart Study. J Gerontol. 53A:1998;M214-M221.
10. Rall L., Rosen C., Dolnikowski G., et al. Protein metabolism in rheumatoid arthritis and aging effects of muscle strength training and tumor necrosis factor-alpha . Arthritis Rheum. 39:1996;1115-1124.
11. Roubenoff R., Dallal G., Wilson P. Predicting body fatness the body mass index vs. estimation by bioelectrical impedance . Am J Public Health. 85:1995;726-728.
12. Roubenoff R., Roubenoff R.A., Cannon J., et al. Rheumatoid cachexia cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation . J Clin Invest. 93:1994;2379-2386.
13. Taaffe D., Pruitt L., Reim J., Butterfield G., Marcus R. Effect of sustained resistance training on basal metabolic rate in older women. J Am Geriatr Soc. 43:1995;465-471.
14. Lindmark E., Diderholm E., Wallentin L., Siegbahn A. Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease. JAMA. 286:2001;2107-2113.
15. Beharka A., Meydani M., Wu D., Leka L., Meydani A., Meydani S. Interleukin-6 production does not increase with age. J Gerontol. 56A:2001;B81-B88.
16. Tilg H., Dinarello C., Mier J. Interleukin-6 and APPs anti-inflammatory and immunosuppressive mediators . Immunol Today. 18:1997;428-432.
17. Fattori E., Cappelletti M., Costa P., et al. Defective inflammatory response in interleukin-6-deficient mice. J Exp Med. 180:1994;1243-1250.
18. Tsujinaka T., Fujita J., Ebisui C., et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest. 97:1996;244-249.
19. Aderka D., Le J., Vilcek J. Interleukin-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol. 143:1989;3517-3522.
20. Roubenoff R., Grinspoon S., Skolnik P., et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol. 283:2002;E138-E145.
21. Yang S., Alanqeeb M., Simpson H., Goldspink G. Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil. 17:1996;487-495.
22. Loughna P., Mason P., Bates P. Regulation of insulin-like growth factor-1 gene expression in skeletal muscle. Symp Soc Exp Biol. 46:1992;319-330.
23. Moore L., Pfeffer A., Chie W., et al. Induction of an acute phase response in lambs causes an increase in plasma levels of GH and IGF-1. J Endocrinol. 144:1995;243-250.
24. Clemmons D.R., Underwood L.E. Nutritional regulation of IGF-1 and IGF binding proteins. Annu Rev Nutr. 11:1991;393-412.
25. Roubenoff R., Baumgartner R., Kiel D., et al. Bioelectrical impedance equations in ambulatory elderly Caucasians. J Gerontol. 52:1997;M129-M136.
26. Rall L., Roubenoff R., Abad L., Dinarello C., Meydani S. The effects of progressive resistance training on immune response in aging and chronic inflammation. Med Sci Sports Exerc. 28:1996;1356-1365.